| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.00063 | 1 |